Found: 7
Select item for more details and to access through your institution.
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 7, p. e2419258, doi. 10.1001/jamanetworkopen.2024.19258
- By:
- Publication type:
- Article
Vaccine Effectiveness against GP-Attended Symptomatic COVID-19 and Hybrid Immunity among Adults in Hungary during the 2022–2023 Respiratory Season Dominated by Different SARS-CoV-2 Omicron Subvariants.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 496, doi. 10.3390/vaccines12050496
- By:
- Publication type:
- Article
Characteristics of the Third COVID-19 Pandemic Wave with Special Focus on Socioeconomic Inequalities in Morbidity, Mortality and the Uptake of COVID-19 Vaccination in Hungary.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 3, p. 388, doi. 10.3390/jpm12030388
- By:
- Publication type:
- Article
Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 1, p. 1, doi. 10.1111/irv.13243
- By:
- Publication type:
- Article
Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically attended influenza: Results of the European I‐MOVE multicentre test‐negative case‐control study, 2011/2012‐2016/2017
- Published in:
- Influenza & Other Respiratory Viruses, 2018, v. 12, n. 5, p. 567, doi. 10.1111/irv.12562
- By:
- Publication type:
- Article
2015/16 I‐MOVE/I‐MOVE+ multicentre case‐control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage‐mismatched influenza B among children.
- Published in:
- Influenza & Other Respiratory Viruses, 2018, v. 12, n. 4, p. 423, doi. 10.1111/irv.12520
- By:
- Publication type:
- Article
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID- 19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
- Published in:
- Eurosurveillance (15607917), 2023, v. 28, n. 47, p. 1, doi. 10.2807/1560-7917.es.2023.28.47.2300186
- By:
- Publication type:
- Article